Results 151 to 160 of about 41,304 (260)

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

JAMA Netw Open
D'Anna L, Gabriele F, Ornello R, Zini A, Paolucci M, Forlivesi S, Migliaccio L, Viola MM, Rizzo AC, Sessa M, Schwarz G, Tortorella R, Prandin G, Banerjee S, Desai G, Pantoni L, Mele F, Scopelliti G, Cova I, Valente M, Maisano D, Bagnato MR, Di Mauro G, Bernocchi F, Di Donna MG, Casolla B, Mahagne MH, Amoretti ME, Morgan L, González L, Rigual R, Fuentes B, Hervás C, Candelaresi P, Andreone V, De Mase A, Spina E, de Sousa DA, Souza MA, Fior A, Serôdio M, Caliandro P, Zauli A, Reale G, Abdelalim A, Ahmed S, Ismail SA, Zhang L, Latimer T, Elboghday M, El Bassiouny A, Roushdy T, Shokri H, Ferrari F, Loizzo ND, Mazzacane F, Guarion M, Barone V, Forti P, Rinaldi G, Rossi M, Laterza V, Frisullo G, Rizzo PA, Broccolini A, Mannino M, Terruso V, Caggiula M, Scalise S, Fonseca AC, Antunes B, Budincevic H, Crnac P, Viticchi G, Silvestrini M, Barba L, Musienko V, Lochner P, Landau B, Buddha S, Khalil R, Piscaglia MG, Minguzzi E, Zedde M, Nasreldein A, Vinciguerra L, Costa L, ElsaidElsayed A, Al Banna M, Tudisco L, Mosconi MG, Merlino G, De Santis F, Sacco S, Foschi M.   +94 more
europepmc   +1 more source

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects. [PDF]

Int J Cancer
Hollander EM, Buma AIG, Leentjens J, Janssen PKC, van den Heuvel MM, Burger DM, Piet B, Ter Heine R.   +7 more
europepmc   +1 more source

Cardiovascular outcomes for Australian women with rheumatic heart disease during pregnancy: A retrospective linked data analysis, 2002–2017

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This retrospective cohort study used linked data to measure the proportion of women with rheumatic heart disease (RHD) who experienced major adverse cardiovascular events (MACE) after 20 weeks of gestation. Before birth, 4.5% of women with initially uncomplicated RHD and 31.8% of women with initially complicated RHD experienced RHD‐MACE.
Ingrid Stacey, Mohammed Junaid, Holger W. Unger, Geraldine Vaughan, Ye’elah Berman, Vicki Wade, Lee Nedkoff, James Marangou, Judith M. Katzenellenbogen   +8 more
wiley   +1 more source

A multicenter prospective real-world cohort study of direct oral anticoagulant use for venous thromboembolism prophylaxis in nephrotic syndrome. [PDF]

BMC Nephrol
Meena P, Kumar N, Panda SK, Kandari S, Prasad GS, Bhargava V, Khandelia V, Malviya P, Rout NK, Das P, Garg A, Mylliemngap B, Kumari P.   +12 more
europepmc   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä, Reijo Sund, Toni Rikkonen, Kai Kaarniranta   +3 more
wiley   +1 more source

Pharmacist-Led Intervention to Enhance Direct Oral Anticoagulant Adherence and Treatment Outcomes in Atrial Fibrillation: A Pragmatic Clinical Trial. [PDF]

Patient Prefer Adherence
Liu SY, Huang YM, Lin SY, Wang CC.
europepmc   +1 more source

P‐CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study

Alimentary Pharmacology &Therapeutics, EarlyView.
In patients with atherothrombotic disease on antithrombotic therapy, P‐CABs demonstrated a significantly superior protective effect against clinically significant upper GI haemorrhage compared to PPIs (aHR 0.22; p = 0.016). This real‐world study highlights P‐CABs as a more potent gastroprotective strategy for high‐risk populations requiring intensive ...
Min Joo Yoon, Soyoung Lee, Hye‐Kyung Jung, Min‐ho Kim, Suna Yu, Eui Sun Jeong, Chung Hyun Tae   +6 more
wiley   +1 more source

Perioperative management of colorectal surgical patients receiving a direct oral anticoagulant: a scoping review, particular emphasis on procedure-specific risks, and pharmacogenomics. [PDF]

Front Cardiovasc Med
Mao J, Qin L, Gao M, Xie J, Li X, Liang Z.   +5 more
europepmc   +1 more source

Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real‐world study in Quebec

British Journal of Haematology, EarlyView.
Summary Haemoglobin SC (HbSC) disease is the second most prevalent form of sickle cell disease, but evidence for hydroxyurea (hydroxycarbamide; HU) to prevent pain episodes was limited until the prospective identification of variables as outcomes for treatment (PIVOT) trial.
Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent‐Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté   +10 more
wiley   +1 more source

A Direct Oral Anticoagulant-Refractory Unusually Large Thrombus Attached to the Implantable Cardioverter-Defibrillator in a Patient on Rivaroxaban: A Case Report. [PDF]

Cureus
Liu XY, Bajpai M, Brew B, Gul A, Nadurata V, Khan Z.   +5 more
europepmc   +1 more source